Tokenized money-market infrastructure that gives businesses and investors access to cash yield.
Bpifrance
Activity from announced rounds
Bpifrance is France’s public investment bank, financing businesses through equity, loans and guarantees and supporting innovation and international expansion.
Its equity activity includes venture capital, growth investment and investments in other funds. Innovation financing can also support research, development and bringing a product to market, so founders may have financing options beyond a conventional equity round.
The appropriate route depends on the project and stage: research funding, a guarantee for borrowing, direct investment and export support serve different needs. Its bank-for-entrepreneurs model connects those instruments with programmes for developing a French business.
Sources
- Rounds participated in
- 9
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 9 First participation on record · 0 follow-on
- Funding in participating rounds
- $215.1M 9 disclosed · full round size, not this investor’s share
By stage
By primary sector
2 more
By country
Rounds
9 in this selectionEdison IA helps small and mid-sized businesses put AI to work through executive training, process diagnosis and deployed business agents.
Hackuity consolidates vulnerability findings from security tools and helps organisations prioritise remediation against their actual exposure.
Delos sells autonomous AI workers that take on defined business tasks through a company’s messaging and software tools.
Market data, analytics and infrastructure that help financial institutions price, trade and manage risk in digital assets.
AI assessment software that helps teachers turn exam papers into editable grading rubrics, review assisted marking and target students’ learning gaps.
Single-cell tumour profiling for oncology teams and pharma and biotech partners, turning routine biopsy samples into clinical insights for treatment selection and drug development.
MAASH makes fermentation-derived mycoprotein ingredients for food manufacturers developing meat blends and alternative-protein products.
Develops an off-the-shelf in vivo immunotherapy platform for solid tumors